Haleon PLC Sponsored ADR (NYSE:HLN) Receives Average Rating of "Moderate Buy" from Analysts

Key Points

• Haleon PLC Sponsored ADR has received an average analyst rating of "Moderate Buy," with a target price of $12.32 over the next year.
• Recent upgrades from analysts include a "strong-buy" rating from BNP Paribas and a "buy" rating from Goldman Sachs.
• The company announced an increase in its semi-annual dividend to $0.0555 per share, marking a yield of 190.0%.

Shares of Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) have received an average rating of "Moderate Buy" from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $12.3250.

A number of research analysts recently commented on the stock. The Goldman Sachs Group raised shares of Haleon from a "neutral" rating to a "buy" rating in a research report on Wednesday, September 10th. BNP Paribas raised Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. BNP Paribas Exane upgraded Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a research report on Tuesday, May 27th. Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Finally, Barclays downgraded Haleon from an "overweight" rating to an "equal weight" rating in a research note on Tuesday.

Institutional Investors Weigh In On Haleon

A number of hedge funds and other institutional investors have recently bought and sold shares of HLN. Hanson & Doremus Investment Management increased its holdings in shares of Haleon by 234.1% in the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company's stock valued at $25,000 after purchasing an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC lifted its position in shares of Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after acquiring an additional 1,491 shares during the period. Banque Transatlantique SA purchased a new stake in shares of Haleon during the 1st quarter worth approximately $27,000. Golden State Wealth Management LLC boosted its stake in shares of Haleon by 107.6% during the 2nd quarter. Golden State Wealth Management LLC now owns 2,721 shares of the company's stock worth $28,000 after acquiring an additional 1,410 shares in the last quarter. Finally, Opal Wealth Advisors LLC acquired a new stake in shares of Haleon in the 1st quarter worth approximately $29,000. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Price Performance

Shares of HLN opened at $9.39 on Thursday. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The firm's fifty day simple moving average is $9.69 and its 200-day simple moving average is $10.19. The firm has a market capitalization of $42.03 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 2.74 and a beta of 0.24. Haleon has a twelve month low of $8.86 and a twelve month high of $11.42.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Shareholders of record on Friday, August 15th will be given a dividend of $0.0555 per share. This represents a yield of 190.0%. The ex-dividend date is Friday, August 15th. This is a positive change from Haleon's previous semi-annual dividend of $0.05. Haleon's payout ratio is presently 28.21%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.